Publications

Bauer, Christina M., Anna M. Ray, Bronwen A. Halstead-Nussloch, Robert G. Dekker, Victoria M. Raymond, Stephen B. Gruber, and Kathleen A. Cooney. “Hereditary prostate cancer as a feature of Lynch syndrome.” Fam Cancer 10, no. 1 (March 2011): 37–42. https://doi.org/10.1007/s10689-010-9388-8.

PMID
20872076
Full Text

Mollberg, N., M. Surati, C. Demchuk, R. Fathi, A. K. Salama, A. N. Husain, T. Hensing, and R. Salgia. “Mind-mapping for lung cancer: towards a personalized therapeutics approach.” Adv Ther 28, no. 3 (March 2011): 173–94. https://doi.org/10.1007/s12325-010-0103-9.

PMID
21337123
Full Text

Armstrong, A. J., M. Haggman, W. M. Stadler, J. R. Gingrich, V. J. Assikis, O. Nordle, G. Forsberg, M. A. Carducci, and R. Pili. “Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups.” Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 126–126. https://doi.org/10.1200/jco.2011.29.7_suppl.126.

Full Text

Farenhorst, M, Hilhorst, A, Thomas, MB, and Knols, BGJ. "Development of fungal applications on netting substrates for malaria vector control." Journal of Medical Entomology 48, no. 2 (March 2011): 305-313.

PMID
21485366
Full Text

Pond, G. R., A. J. Armstrong, B. A. Wood, M. Brookes, L. H. Leopold, J. M. Burke, J. R. Caton, M. T. Fleming, and G. Sonpavde. “Assessment of two prognostic risk group methods to predict outcomes with docetaxel-based therapy in men with metastatic castration-resistant prostate cancer (mCRPC).” Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 185–185. https://doi.org/10.1200/jco.2011.29.7_suppl.185.

Full Text

Pilie, PG, Ibarra-Drendall, C, Troch, MM, Broadwater, G, Barry, WT, Petricoin, EF, Wulfkuhle, JD, Liotta, LA, Lem, S, Baker, JC, Stouder, A, Ford, AC, Wilke, LG, Zalles, CM, Mehta, P, Williams, J, Shivraj, M, Su, Z, Geradts, J, Yu, D, and Seewaldt, VL. "Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data." Cancer Epidemiol Biomarkers Prev 20, no. 3 (March 2011): 476-482.

PMID
21242333
Full Text

Sonpavde, G., G. R. Pond, W. R. Berry, R. De Wit, M. A. Eisenberger, I. Tannock, and A. J. Armstrong. “Association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.” Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 118–118. https://doi.org/10.1200/jco.2011.29.7_suppl.118.

Full Text

Bruner, DW, Hanisch, LJ, Reeve, BB, Trotti, AM, Schrag, D, Sit, L, Mendoza, TR, Minasian, L, O'Mara, A, Denicoff, AM, Rowland, JH, Montello, M, Geoghegan, C, Abernethy, AP, Clauser, SB, Castro, K, Mitchell, SA, Burke, L, Trentacosti, AM, and Basch, EM. "Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)." Translational Behavioral Medicine 1, no. 1 (March 2011): 110-122.

PMID
24073038
Full Text

Sampson, John H., Kenneth D. Aldape, Gary E. Archer, April Coan, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, et al. “Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.” Neuro Oncol 13, no. 3 (March 2011): 324–33. https://doi.org/10.1093/neuonc/noq157.

PMID
21149254
Full Text

Zhang, Yang, Erich M. Sturgis, Mark E. Zafereo, Qingyi Wei, and Guojun Li. “p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.” Cancer 117, no. 6 (March 2011): 1227–35. https://doi.org/10.1002/cncr.25605.

PMID
21381012
Full Text

Pages